© 2019 IPHARMA

  • Facebook Social Icon
  • LinkedIn Social Icon
  • YouTube Social  Icon
  • Instagram Social Icon

IPHARMA is a contract research organization specialized in conducting clinical trials of investigational drugs in the Russian Federation and the EAEU.

 

IPHARMA is a member of ChemRar High-Tech Center group of companies and an accredited partner of Skolkovo Innovation Center.

 

Download our company brochure

IPHARMA did a great job!

25.12.2017

IPHARMA received the Ministry of Health approval to conduct two clinical trials

21.12.2017

The Quality Assurance Forum sponsored by IPHARMA will be held in Skolkovo on December, 14th

29.11.2017

1/4
Please reload

Quick facts 2012-2019
#1 CRO in Russia according to the results of 2018.
Leading positions on the market of Russian innovative drugs according to ACTO analytical report for 2013 - 2018.

95+

110+

65+

370+

1180+

5100+

10

Products in clinical pipeline

Protocols written

 

Regulatory approvals

 

Clinical sites

 

Healthy volunteers enrolled

 

Patients enrolled

 

Original drugs filed for registration

Cases and webinars

​IPHARMA continue to hold a series of webinars on Youtube channel.

We share our knowledge and experience in clinical research with a wide audience by means of free webinars in witch we discuss the current issues of drug development and safety.

Advantages of working with IPHARMA

1. Leading positions on the market of Russian innovative drugs according to ACTO analytical report for 2013 - 2018.

2. Opportunities for drug localization, investments, and market access.

3. Full cycle of drug development: formulation, batches, QC, preclinical, clinical.

4. Medical and PV expertise with access to top scientists and KOLs.

5. Quality management systems and experienced staff.

IPHARMA contacts

 

5, Nobel street, Skolkovo Innovative Centre,  Moscow, 143026, Russia


Tel.: +7 (495) 276-11-43 
Fax: +7 (495) 276-11-47


E-mail: info@ipharma.ru

Personal data processing and storage policy

Sk_resident.jpg